Modulating the nuclear receptor-cofactor interaction : characterization and inhibition

Editor's evaluation: Molecular basis of ligand-dependent Nurr1-RXRα activation

Lipid homeostasis is controlled by various nuclear receptors (NRs), including the peroxisome proliferator-activated receptors (PPARalpha, delta, and gamma), which sense lipid levels and regulate their metabolism. Here we demonstrate that human PPARs have a high basal activity and show ligand-independent coactivator (CoA) association comparable with the NR constitutive androstane receptor. Using PPARgamma as an example, we found that four different amino acid groups contribute to the ligand-independent stabilization of helix 12 of the PPAR ligand-binding domain. These are: (i) Lys329 and Glu499, mediating a charge clamp-type stabilization of helix 12 via a CoA bridge; (ii) Glu352, Arg425, and Tyr505, directly stabilizing the helix via salt bridges and hydrogen bonds; (iii) Lys347 and Asp503, interacting with each other as well as contacting the CoA; and (iv) His351, Tyr(355), His477, and Tyr501, forming a hydrogen bond network. These amino acids are highly conserved within the PPAR subfamily, suggesting that the same mechanism may apply for all three PPARs. Phylogenetic trees of helix 12 amino acid and nucleotide sequences of all crystallized NRs and all human NRs, respectively, indicated a close relationship of PPARs with constitutive androstane receptor and other constitutive active members of the NR superfamily. Taking together, the ligand-independent tight control of the position of the PPAR helix 12 provides an effective alternative for establishing an interaction with CoA proteins. This leads to high basal activity of PPARs and provides an additional view on PPAR signaling.

The functional interaction between the peroxisome proliferator-activated receptor gamma (PPARgamma) and its coactivator PGC-1alpha is crucial for the normal physiology of PPARgamma and its pharmacological response to antidiabetic treatment with rosiglitazone. Here we report the crystal structure of the PPARgamma ligand-binding domain bound to rosiglitazone and to a large PGC-1alpha fragment that contains two LXXLL-related motifs. The structure reveals critical contacts mediated through the first LXXLL motif of PGC-1alpha and the PPARgamma coactivator binding site. Through a combination of biochemical and structural studies, we demonstrate that the first LXXLL motif is the most potent among all nuclear receptor coactivator motifs tested, and only this motif of the two LXXLL-related motifs in PGC-1alpha is capable of binding to PPARgamma. Our studies reveal that the strong interaction of PGC-1alpha and PPARgamma is mediated through both hydrophobic and specific polar interactions. Mutations within the context of the full-length PGC-1alpha indicate that the first PGC-1alpha motif is necessary and sufficient for PGC-1alpha to coactivate PPARgamma in the presence or absence of rosiglitazone. These results provide a molecular basis for specific recruitment and functional interplay between PPARgamma and PGC-1alpha in glucose homeostasis and adipocyte differentiation.

Nuclear hormone receptors (NHRs) are major regulators of development and homeostasis in multiple organ systems. These proteins are ligand-modulated transcription factors that regulate gene expression in response to changes in circulating levels of their cognate hormones or hormone analogs. When NHRs bind ligands, they adopt distinct conformations that enable or disable the binding of coregulator proteins in a manner that reflects the agonist versus antagonist character of the ligand. Using the estrogen receptor ligand binding domain as a representative member of the NHR family, we show the development of functional protein microarrays and use them to explore coactivator recruitment and NHR homo- and heterodimer functionality. These NHR protein microarrays can be fabricated in either a forward mode (coactivator recruited to printed NHR) or a reversed mode (NHR recruited to printed coactivator). From these microarrays, we can predict the potency and pharmacological character of various NHR ligands through the nature of their coactivator recruitment. Additionally different coactivator proteins can be functionally classified and their affinity for NHRs can be quantified. NHR-selective antagonist ligands and small molecule coactivator mimics disrupt the coactivator-NHR complex. This novel proteomic approach was also used to assess coactivator recruitment to explore heterodimer functionality. Heterodimers of the estrogen receptor were found only to recruit coactivators when both monomers are bound with agonist ligands, an observation that provides an insight into the complex biology of hormones that act on tissues containing both NHR subtypes. We can extend this NHR proteomic approach to the analysis of multidomain full-length NHR constructs and can concurrently monitor the activation state of different classes of NHRs with a mixture of endogenous or synthetic ligands of varying NHR selectivity and pharmacology.

Chapter 21 Inhibitors of Nuclear Hormone Receptor/Coactivator Interactions

CBP, cAMP-response element-binding protein (CREB)-binding protein, plays an important role as a general cointegrator of various signaling pathways and interacts with a large number of transcription factors. Interactions of CBP with ligand binding domains (LBDs) of nuclear receptors are mediated by LXXLL motifs, as are those of p160 proteins, although the number, distribution, and precise sequences of the motifs differ. We used a large N-terminal fragment of murine CBP to map by biochemical methods and NMR spectroscopy the interaction domain of CBP with the LBDs of several nuclear receptors. We show that distinct zones of that fragment are involved in the interactions: a 20-residue segment containing the LXXLL motif (residues 61-80) is implicated in the interaction with all three domains tested (peroxisome proliferator-activated receptor gamma-LBD, retinoid X receptor alpha-LBD, and estrogen-related receptor gamma-LBD), whereas a second N-terminal well conserved block of around 25 residues centered on a consensus L(40)PDEL(44) motif constitutes a secondary motif of interaction with peroxisome proliferator-activated receptor gamma-LBD. Sequence analysis reveals that both zones are well conserved in all vertebrate p300/CBP proteins, suggesting their functional importance. Interactions of p300/CBP coactivators with the LBDs of nuclear receptors are not limited to the canonical LXXLL motifs, involving both a longer contiguous segment around the motif and, for certain domains, an additional zone.

The liver X receptor, LXRα, is an important regulator of genes involved in metabolism and inflammation. The mechanism of communication between the cofactor peptide and the ligand in the ligand-binding pocket is a crucial and often discussed issue for the nuclear receptors (NRs), but such allosteric signaling pathways are difficult to detect and the transmission mechanism remains elusive. Here, we apply the anisotropic thermal diffusion method to the LXRα with bound coactivator and ligand. We detected a possible communication pathway between the coactivator peptide and the ligand. The signal is transmitted both through the receptor backbone and side chains. A key signaling residue is the first leucine in the cofactor peptide recognition motif LXXLL, which is conserved within the NR cofactors, suggesting a general mechanism for allosteric signaling. Furthermore, we studied the LXR receptor and cofactor molecular interactions in detail using molecular dynamics simulations. The protein-protein interaction patterns in the complexes of nine different cofactor peptides and holo-LXRα were characterized, revealing the importance of the receptor-cofactor charge clamp interaction. Specific, but infrequently occurring interactions were observed toward the cofactor peptide C-terminal residues. Thus, additional specificity between LXRα and its cofactors is likely to be found in molecular interactions outside the cofactor peptide or in other biological factors.

Inverse agonists of the constitutively active human estrogen-related receptor alpha (ERRalpha, NR3B1) are of potential interest for several disease indications (e.g. breast cancer, metabolic diseases, or osteoporosis). ERRalpha is constitutively active, because its ligand binding pocket (LBP) is practically filled with side chains (in particular with Phe(328), which is replaced by Ala in ERRbeta and ERRgamma). We present here the crystal structure of the ligand binding domain of ERRalpha (containing the mutation C325S) in complex with the inverse agonist cyclohexylmethyl-(1-p-tolyl-1H-indol-3-ylmethyl)-amine (compound 1a), to a resolution of 2.3A(.) The structure reveals the dramatic multiple conformational changes in the LBP, which create the necessary space for the ligand. As a consequence of the new side chain conformation of Phe(328) (on helix H3), Phe(510)(H12) has to move away, and thus the activation helix H12 is displaced from its agonist position. This is a novel mechanism of H12 inactivation, different from ERRgamma, estrogen receptor (ER) alpha, and ERbeta. H12 binds (with a surprising binding mode) in the coactivator groove of its ligand binding domain, at a similar place as a coactivator peptide. This is in contrast to ERRgamma but resembles the situation for ERalpha (raloxifene or 4-hydroxytamoxifen complexes). Our results explain the novel molecular mechanism of an inverse agonist for ERRalpha and provide the basis for rational drug design to obtain isotype-specific inverse agonists of this potential new drug target. Despite a practically filled LBP, the finding that a suitable ligand can induce an opening of the cavity also has broad implications for other orphan nuclear hormone receptors (e.g. the NGFI-B subfamily).

Background: Crystallographic structures of nuclear receptor ligand binding domains provide a static model of a receptor stably wrapped around an internalized ligand. Understanding the dynamics of a receptor at different stages of ligand binding has been hampered by the paucity of crystal structures for unliganded nuclear receptors. Molecular dynamic models have been constructed for some nuclear receptors to fill that void.Methods: The molecular simulation docking program MORDOR (MOlecular Recognition with a Driven dynamics OptimizeR)(1) was used to study the structural dynamics of the androgen receptor ligand binding domain (AR LBD) modeled from the static structure of the AR LBD bound to testosterone (T) (PDB ID: 2AM9). The goals of the study were to understand a) the dynamic interaction of the T in its binding pocket, b) AR LBD structural flexibilities that permit T entry/exit from the binding pocket and c) a model of the unliganded AR LBD.Results: Modeling AR LBD structure flexibility over time revealed possible alternative dynamic structures, including those without ligand, overlaid against the canonical nuclear receptor structure. The model dynamically tracks the structural changes as a ligand enters into the ligand binding domain and nestles into the ligand binding pocket. The model predicted the appearance of alpha helices within the AR LBD that transiently fold/unfold during the ligand entry phases. Once in the pocket, the ligand itself remains very dynamic in a still flexible pocket. The model predicted also AR LBD amino acids that sequentially interact with the ligand during its dynamic entry into the AR LBD. Intriguingly, those AR amino acids include those mutated in castration-resistant prostate tumors that continue to grow during androgen suppression therapy. Functional studies showed those mutant ARs had a primary consequence of enhancing response to lower level T, and other androgens, consistent with their role in creating a higher affinity AR that can scavenge low-level androgens in an androgen-suppressed patient.Conclusions: The molecular model of T binding to the AR LBD suggests a degree of structural dynamism not evident in the crystallographic structures commonly associated with nuclear receptors. Some AR mutations activating prostate tumor growth may do so by impacting androgen entry/exit, rather than by altering androgen fit into the ligand binding pocket.Reference: (1) Guilbert C, James TL (2008) J Chem Inf Model. 2008 48(6): 1257-1268. doi: 10.1021/ci8000327

The interaction of coactivators with the ligand-binding domain of nuclear receptors (NRs) is mediated by amphipathic alpha-helices containing the signature motif LXXLL. TRAP220 contains two LXXLL motifs (LXM1 and LXM2) that are required for its interaction with NRs. Here we show that the nuclear receptor interaction domain (NID) of TRAP220 interacts weakly with Class I NRs. In contrast, SRC1 NID binds strongly to both Class I and Class II NRs. Interaction assays using nine amino acid LXXLL core motifs derived from SRC1 and TRAP220 revealed no discriminatory NR binding preferences. However, an extended LXM1 sequence containing amino acids -4 to +9, (where the first conserved leucine is +1) showed selective binding to thyroid hormone receptor and reduced binding to estrogen receptor. Replacement of either TRAP220 LXXLL motif with the corresponding 13 amino acids of SRC1 LXM2 strongly enhanced the interaction of the TRAP220 NID with the estrogen receptor. Mutational analysis revealed combinatorial effects of the LXM1 core and flanking sequences in the determination of the NR binding specificity of the TRAP220 NID. In contrast, a mutation that increased the spacing between TRAP220 LXM1 and LXM2 had little effect on the binding properties of this domain. Thus, a 13-amino acid sequence comprising an extended LXXLL motif acts as the key determinant of the NR binding specificity of TRAP220. Finally, we show that the NR binding specificity of full-length TRAP220 can be altered by swapping extended LXM sequences.

Transcriptional regulation by nuclear receptors is controlled by the concerted action of coactivator and corepressor proteins. The product of the thyroid hormone-regulated mammalian gene hairless (Hr) was recently shown to function as a thyroid hormone receptor corepressor. Here we report that Hr acts as a potent repressor of transcriptional activation by RORalpha, an orphan nuclear receptor essential for cerebellar development. In contrast to other corepressor-nuclear receptor interactions, Hr binding to RORalpha is mediated by two LXXLL-containing motifs, a mechanism associated with coactivator interaction. Mutagenesis of conserved amino acids in the ligand binding domain indicates that RORalpha activity is ligand-dependent, suggesting that corepressor activity is maintained in the presence of ligand. Despite similar recognition helices shared with coactivators, Hr does not compete for the same molecular determinants at the surface of the RORalpha ligand binding domain, indicating that Hr-mediated repression is not simply through displacement of coactivators. Remarkably, the specificity of Hr corepressor action can be transferred to a retinoic acid receptor by exchanging the activation function 2 (AF-2) helix. Repression of the chimeric receptor is observed in the presence of retinoic acid, demonstrating that in this context, Hr is indeed a ligand-oblivious nuclear receptor corepressor. These results suggest a novel molecular mechanism for corepressor action and demonstrate that the AF-2 helix can play a dynamic role in controlling corepressor as well as coactivator interactions. The interaction of Hr with RORalpha provides direct evidence for the convergence of thyroid hormone and RORalpha-mediated pathways in cerebellar development.

PGC-1beta is a transcriptional coactivator that enhances strongly and in a hormone-dependent manner the activity of the estrogen receptor alpha (ERalpha) while having only weak effects on similar steroid hormone receptors, such as ERbeta or the glucocorticoid receptor. Notably, PGC-1beta enhances ERalpha transcriptional activity not only in response to agonist ligands, such as estradiol, but also to selective ER modulators, such as tamoxifen. Here, we dissect the molecular mechanisms underlying the ability of PGC-1beta to act selectively on ERalpha and to promote the agonist activity of tamoxifen. We show that receptor selectivity is achieved by PGC-1beta interactions with not just the ligand binding domain (LBD), which is highly conserved among nuclear receptors, but also the N-terminal domain and the hinge/AF-2a region of ERalpha, which are less well conserved. PGC-1beta interacts directly with the hinge/AF-2a and LBD regions but indirectly and via the coactivator SRC-1 with the N-terminal domain. The three ERalpha surfaces and SRC-1 collectively enable efficient coactivation by PGC-1beta. Similar ERalpha surfaces and interactions enable PGC-1beta to coactivate transcription by tamoxifen-bound ERalpha. Surprisingly, PGC-1beta coactivation of tamoxifen-bound ERalpha depends partially on one of the LXXLL motifs of PGC-1beta and on Lys(362) of the ERalpha LBD (i.e. surfaces implicated in agonist-dependent interactions). Our findings suggest that tamoxifen-induced changes in the ERalpha LBD promote interactions with the coactivator PGC-1beta, which then cooperates with SRC-1 to enable tamoxifen agonism.

hormone response element peroxisome proliferator-activated receptor thyroid hormone receptor estrogen receptor ligand binding domain nuclear receptor corepressor silencing mediator of retinoic acid and thyroid hormone receptor imitation SWI cAMP response element-binding protein CREB-binding protein histone acetyltransferase mitogen-activated protein histone deacetylase steroid receptor coactivator RAR interacting protein glucocorticoid receptor interacting protein T3R receptor associated protein vitamin receptor D interacting protein Members of the nuclear receptor superfamily directly activate or repress target genes by binding to hormone response elements (HREs)1 in promoter or enhancer regions, and by binding to other DNA sequence-specific activators and can inhibit the transcriptional activities of other classes of transcription factors by transrepression. Hormone response elements provide specificity to receptor homodimer heterodimer binding (reviewed in Ref. 2Bourguet W. Germain P. Gronemeyer H. Trends Pharm. Sci. 2000; 21: 381-388Abstract Full Text Full Text PDF PubMed Scopus (397) Google Scholar). Nuclear receptor functions are directed by specific activation domains, referred to as activation function 1 (AF-1), which resides in the N terminus, and activation function 2 (AF-2), which resides in the C-terminal ligand binding domain (LBD) (reviewed in Ref. 1Glass C.K. Rosenfeld M.G. Genes Dev. 2000; 14: 121-141Crossref PubMed Google Scholar). Regulation of gene transcription by nuclear receptors requires the recruitment of proteins characterized as coregulators, with ligand-dependent exchange of corepressors for coactivators serving as the basic mechanism for switching gene repression to activation. In this review, we discuss biochemical and genetic studies suggesting that coregulatory complexes are differentially utilized in both a cell- and promoter-specific fashion to activate or repress gene transcription. These coregulatory components, themselves targets of diverse intracellular signaling pathways, provide a combinatorial code for tissue- and gene-specific responses, utilizing both enzymatic and platform assembly functions to mediate the actions of nuclear receptor genetic programs critical for developmental and homeostatic processes in metazoan organisms. A diverse group of proteins have emerged as potential coactivators for nuclear receptors. Ligand-dependent recruitment of coactivators is dependent on AF-2, which consists of a short conserved helical sequence within the C terminus of the LBD (2Bourguet W. Germain P. Gronemeyer H. Trends Pharm. Sci. 2000; 21: 381-388Abstract Full Text Full Text PDF PubMed Scopus (397) Google Scholar). Biochemical and expression cloning approaches have been used to identify a large number of factors that interact with nuclear receptors in either a ligand-independent or a ligand-dependent manner and are often components of large multiprotein complexes. Many of these factors are capable of potentiating nuclear receptor activity in transient cotransfection assays. In addition, a distinct set of coactivators is associated with the AF-1 domain. As the number of potential coregulators clearly exceeds the capacity for direct interaction by a single receptor, the most plausible hypothesis is that transcriptional activation by nuclear receptors involves the actions of multiple factors. These factors act in a sequential and/or combinatorial manner to reorganize chromatin templates and to modify and recruit basal factors and RNA polymerase II (3Wu C. J. Biol. Chem. 1997; 272: 28171-28174Abstract Full Text Full Text PDF PubMed Scopus (200) Google Scholar, 4Wade P.A. Wollfe A.P. Curr. Biol. 1999; 9: R221-R224Abstract Full Text Full Text PDF PubMed Scopus (40) Google Scholar). As chromatinized transcription units are “repressed” compared with naked DNA, a critical aspect of gene activation involves nucleosomal remodeling (reviewed in Refs. 3Wu C. J. Biol. Chem. 1997; 272: 28171-28174Abstract Full Text Full Text PDF PubMed Scopus (200) Google Scholar, 4Wade P.A. Wollfe A.P. Curr. Biol. 1999; 9: R221-R224Abstract Full Text Full Text PDF PubMed Scopus (40) Google Scholar, 5Struhl K. Cell. 1999; 98: 1-4Abstract Full Text Full Text PDF PubMed Scopus (373) Google Scholar). Two general classes of chromatin remodeling factors that appear to play critical roles in transcriptional activation by nuclear receptors have been identified. These are ATP-dependent nucleosome remodeling complexes and factors that contain histone acetyltransferase activity. The yeast SWI·SNF complex facilitates the binding of sequence-specific transcription factors to nucleosomal DNA and can cause local changes in chromatin structure in an ATP-dependent manner (3Wu C. J. Biol. Chem. 1997; 272: 28171-28174Abstract Full Text Full Text PDF PubMed Scopus (200) Google Scholar, 4Wade P.A. Wollfe A.P. Curr. Biol. 1999; 9: R221-R224Abstract Full Text Full Text PDF PubMed Scopus (40) Google Scholar, 5Struhl K. Cell. 1999; 98: 1-4Abstract Full Text Full Text PDF PubMed Scopus (373) Google Scholar, 6Pazin M.J. Kadonaga J.T. Cell. 1997; 88: 737-740Abstract Full Text Full Text PDF PubMed Scopus (270) Google Scholar, 7Pazin M.J. Kadonaga J.T. Cell. 1997; 89: 325-328Abstract Full Text Full Text PDF PubMed Scopus (773) Google Scholar, 8Mizzen C.A. Yang X.-J. Kokubo T. Brownell J.E. Bannister A.J. Owen-Hughes T. Workman J. Wang L. Berger S.L. Kouzarides T. Nakatani Y. Allis C.D. Cell. 1996; 87: 1261-1270Abstract Full Text Full Text PDF PubMed Scopus (628) Google Scholar, 9Ogryzko V.V. Kotani T. Zhang R.L. Howard S.T. Yang X.J. Howard B.H. Qin J. Nakatani Y. Cell. 1998; 94: 35-44Abstract Full Text Full Text PDF PubMed Scopus (469) Google Scholar, 10Bannister A.J. Kouzarides T. Nature. 1996; 384: 641-643Crossref PubMed Scopus (1549) Google Scholar, 11Ogryzko V.V. Schiltz R.L. Russanova V. Howard B.H. Nakatani Y. Cell. 1996; 87: 953-959Abstract Full Text Full Text PDF PubMed Scopus (2448) Google Scholar, 12Grant P.A. Duggan L. Cote J. Roberts S.M. Brownell J.E. Candau R. Ohba R. Owen-Hughes T. Allis C.D. Winston F. Berger S.L. Workman J.L. Genes Dev. 1997; 11: 1640-1650Crossref PubMed Scopus (897) Google Scholar). Mammalian homologues of Drosophila SWI2/SNF2 such as BRG1/hBrm function as components of large multiprotein complexes. Transfection of ATPase-defective alleles of either Brg1 orhBrm into several mammalian cell lines leads to a significant decrease in the ability of several nuclear receptors to activate transcription (3Wu C. J. Biol. Chem. 1997; 272: 28171-28174Abstract Full Text Full Text PDF PubMed Scopus (200) Google Scholar, 4Wade P.A. Wollfe A.P. Curr. Biol. 1999; 9: R221-R224Abstract Full Text Full Text PDF PubMed Scopus (40) Google Scholar, 5Struhl K. Cell. 1999; 98: 1-4Abstract Full Text Full Text PDF PubMed Scopus (373) Google Scholar, 6Pazin M.J. Kadonaga J.T. Cell. 1997; 88: 737-740Abstract Full Text Full Text PDF PubMed Scopus (270) Google Scholar). Remodeling complexes containing ISWI (imitation SWI) may also be involved in nuclear receptor function (7Pazin M.J. Kadonaga J.T. Cell. 1997; 89: 325-328Abstract Full Text Full Text PDF PubMed Scopus (773) Google Scholar, 8Mizzen C.A. Yang X.-J. Kokubo T. Brownell J.E. Bannister A.J. Owen-Hughes T. Workman J. Wang L. Berger S.L. Kouzarides T. Nakatani Y. Allis C.D. Cell. 1996; 87: 1261-1270Abstract Full Text Full Text PDF PubMed Scopus (628) Google Scholar, 9Ogryzko V.V. Kotani T. Zhang R.L. Howard S.T. Yang X.J. Howard B.H. Qin J. Nakatani Y. Cell. 1998; 94: 35-44Abstract Full Text Full Text PDF PubMed Scopus (469) Google Scholar, 10Bannister A.J. Kouzarides T. Nature. 1996; 384: 641-643Crossref PubMed Scopus (1549) Google Scholar, 11Ogryzko V.V. Schiltz R.L. Russanova V. Howard B.H. Nakatani Y. Cell. 1996; 87: 953-959Abstract Full Text Full Text PDF PubMed Scopus (2448) Google Scholar). Rates of gene transcription roughly correlate with the degree of histone acetylation, with hyperacetylated regions of the genome appearing to be more actively transcribed than hypoacetylated regions (reviewed in Ref. 7Pazin M.J. Kadonaga J.T. Cell. 1997; 89: 325-328Abstract Full Text Full Text PDF PubMed Scopus (773) Google Scholar). The specific recruitment of a complex with histone acetyltransferase activity to a promoter may play a critical role in overcoming repressive effects of chromatin structure on transcription (4Wade P.A. Wollfe A.P. Curr. Biol. 1999; 9: R221-R224Abstract Full Text Full Text PDF PubMed Scopus (40) Google Scholar, 5Struhl K. Cell. 1999; 98: 1-4Abstract Full Text Full Text PDF PubMed Scopus (373) Google Scholar, 6Pazin M.J. Kadonaga J.T. Cell. 1997; 88: 737-740Abstract Full Text Full Text PDF PubMed Scopus (270) Google Scholar, 7Pazin M.J. Kadonaga J.T. Cell. 1997; 89: 325-328Abstract Full Text Full Text PDF PubMed Scopus (773) Google Scholar). This concept was further supported by the subsequent finding that the mammalian Gcn5 orthologues, including p/CAF, CREB-binding protein (CBP), adenovirus E1A-binding protein p300, and TAFII250, each possess intrinsic histone acetyltransferase (HAT) activity (7Pazin M.J. Kadonaga J.T. Cell. 1997; 89: 325-328Abstract Full Text Full Text PDF PubMed Scopus (773) Google Scholar, 8Mizzen C.A. Yang X.-J. Kokubo T. Brownell J.E. Bannister A.J. Owen-Hughes T. Workman J. Wang L. Berger S.L. Kouzarides T. Nakatani Y. Allis C.D. Cell. 1996; 87: 1261-1270Abstract Full Text Full Text PDF PubMed Scopus (628) Google Scholar, 9Ogryzko V.V. Kotani T. Zhang R.L. Howard S.T. Yang X.J. Howard B.H. Qin J. Nakatani Y. Cell. 1998; 94: 35-44Abstract Full Text Full Text PDF PubMed Scopus (469) Google Scholar, 10Bannister A.J. Kouzarides T. Nature. 1996; 384: 641-643Crossref PubMed Scopus (1549) Google Scholar, 11Ogryzko V.V. Schiltz R.L. Russanova V. Howard B.H. Nakatani Y. Cell. 1996; 87: 953-959Abstract Full Text Full Text PDF PubMed Scopus (2448) Google Scholar). Conversely, the discovery that a mammalian histone deacetylase (HDAC) was a homologue of the yeast corepressor, RPD3 (13Taunton J. Hassig C.A. Schreiber S.L. Science. 1996; 272: 408-411Crossref PubMed Scopus (1569) Google Scholar), gave rise to the hypothesis that regulated activation events might involve the exchange of complexes containing histone deacetylase functions with those containing histone acetyltransferase activity (Fig. 1). It appears that in most cases the acetyltransferases are not directly recruited to nuclear receptors but associate with other coactivators that exhibit higher affinity for the liganded receptor. The acetyltransferase functions of factors such as CBP/p300 are directly required for enhanced transcription on chromatinized templates (14Kraus W. Manning E. Kadonaga J. Mol. Cell Biol. 1999; 19: 8123-8135Crossref PubMed Scopus (203) Google Scholar). A large number of proteins that are recruited in a ligand-dependent fashion have the capacity to enhance transcriptional activation by transient transfection. Several insights into the mechanisms by which coactivator complexes are recruited to nuclear receptors in a ligand-dependent manner have been provided by the initial identification of the p160 family of nuclear receptor coactivators, referred to as SRC-1/NCOA1, TIF2/GRIP1, and p/CIP/A1B1/ACTR/RAC/TRAM-1 (reviewed in Ref. 15McKenna N.J. Lanz R.B. O'Malley B.W. Endocr. Rev. 1999; 20: 321-344Crossref PubMed Scopus (1669) Google Scholar). The p160 factors consist of three members that exhibit a common domain structure, illustrated in Fig. 1. The central conserved domain mediates ligand-dependent interactions with the nuclear receptor LBD, whereas the conserved C-terminal transcriptional activation domains mediate interactions with either CBP/p300 or protein-arginine methyltransferase (16Chen D. Ma H. Hong H. Koh S.S. Huang S.-M. Schurter B.T. Aswad D.W. Stallcup M.R. Science. 1999; 284: 2174-2176Crossref PubMed Scopus (1019) Google Scholar, 17Koh S. Chen D. Lee Y. Stallcup M. J. Biol. Chem. 2001; 276: 1089-1098Abstract Full Text Full Text PDF PubMed Scopus (310) Google Scholar). Based on the presence of three regulatory domains, members of the p160 family have been suggested to function as coactivators, at least in part, by serving as adapter molecules that recruit CBP and/or p300 complexes to promoter-bound nuclear receptors in a ligand-dependent manner (18Kurokawa R. Kalafus D. Ogliastro M.-H. Kioussi C. Xu L. Torchia J. Rosenfeld M.G. Glass C.K. Science. 1998; 279: 700-703Crossref PubMed Scopus (199) Google Scholar, 19Torchia J. Rose D.W. Inostroza J. Kamei Y. Westin S. Glass C.K. Rosenfeld M.G. Nature. 1997; 387: 677-684Crossref PubMed Scopus (1112) Google Scholar). Biochemical studies have also demonstrated strong ligand-dependent interactions between nuclear receptors and p140 factors, probably representing the coregulator RIP140, which results in a reproductive defect in female mice on gene deletion (20White R. Leonaardsson G. Roswell G. Jacobs I. Milligan S. Parker M. Nat. Med. 2000; 6: 1368-1374Crossref PubMed Scopus (165) Google Scholar). Analysis of the nuclear receptor interaction domain of the p160 family led to the identification of three repeated motifs with a consensus sequence LXXLL in which L represents leucine andX represents any amino acid. The LXXLL motif has been found to be necessary and sufficient for ligand-dependent interactions with the nuclear receptor ligand binding domain (19Torchia J. Rose D.W. Inostroza J. Kamei Y. Westin S. Glass C.K. Rosenfeld M.G. Nature. 1997; 387: 677-684Crossref PubMed Scopus (1112) Google Scholar, 21Heery D.M. Kalkhoven E. Hoare S. Parker M.G. Nature. 1997; 387: 733-736Crossref PubMed Scopus (1800) Google Scholar, 22Nolte R.T. Wisely G.B. Westin S. Cobb J.E. Lambert M.H. Kurokawa R. Rosenfeld M.G. Willson T.M. Glass C.K. Milburn M.V. Nature. 1998; 395: 137-143Crossref PubMed Scopus (1714) Google Scholar, 23Feng W. Ribeiro R.C.J. Wagner R.L. Nguyen H. Apriletti J.W. Fletterick R.J. Baxter J.D. Kushner P.J. West B.L. Science. 1998; 280: 1747-1749Crossref PubMed Scopus (520) Google Scholar, 24Darimont B.D. Wagner R.L. Apriletti J.W. Stallcup M.R. Kushner P.J. Baxter J.D. Fletterick R.J. Yamamoto K.R. Genes Dev. 1998; 12: 3343-3356Crossref PubMed Scopus (834) Google Scholar, 25Shiau A.K. Barstad D. Loria P.M. Cheng L. Kushner P.J. Agard D.A. Greene G.L. Cell. 1998; 95: 927-937Abstract Full Text Full Text PDF PubMed Scopus (2304) Google Scholar). Structural studies of the PPARγ, ER, and T3R ligand binding domains complexed to fragments of the p160 nuclear receptor interaction domains revealed that these motifs form short α helices (22Nolte R.T. Wisely G.B. Westin S. Cobb J.E. Lambert M.H. Kurokawa R. Rosenfeld M.G. Willson T.M. Glass C.K. Milburn M.V. Nature. 1998; 395: 137-143Crossref PubMed Scopus (1714) Google Scholar, 23Feng W. Ribeiro R.C.J. Wagner R.L. Nguyen H. Apriletti J.W. Fletterick R.J. Baxter J.D. Kushner P.J. West B.L. Science. 1998; 280: 1747-1749Crossref PubMed Scopus (520) Google Scholar, 24Darimont B.D. Wagner R.L. Apriletti J.W. Stallcup M.R. Kushner P.J. Baxter J.D. Fletterick R.J. Yamamoto K.R. Genes Dev. 1998; 12: 3343-3356Crossref PubMed Scopus (834) Google Scholar, 25Shiau A.K. Barstad D. Loria P.M. Cheng L. Kushner P.J. Agard D.A. Greene G.L. Cell. 1998; 95: 927-937Abstract Full Text Full Text PDF PubMed Scopus (2304) Google Scholar), with multiple LXXLL motifs within a single coactivator mediating cooperative interactions with nuclear receptor dimers or heterodimers. The LXXLL helix is oriented and positioned at each end by a “charge-clamp” consisting of a conserved lysine in helix 3 of the ligand binding domain and a conserved glutamate in the AF-2 helix. These residues grip the LXXLL helix so that the internal leucine residues can pack into a hydrophobic pocket in the receptor C terminus. Most nuclear receptor coactivators have proved to contain functionally important LXXLL helices, with additional residues contributing to binding specificity (e.g. Refs. 26McInerney E.M. Rose D.W. Flynn S.E. Westin S. Mullen T.-M. Krones A. Inostroza J. Torchia J. Nolte R.T. Assa-Munt N. Milburn M.V. Glass C.K. Rosenfeld M.G. Genes Dev. 1998; 12: 3357-3368Crossref PubMed Scopus (531) Google Scholar and 27Heery D. Hoare S. J. Biol. Chem. 2001; 276: 6695-6702Abstract Full Text Full Text PDF PubMed Scopus (141) Google Scholar). Furthermore, these contacts are sensitive to conformational changes induced by structurally distinct ligands. Many additional factors have been demonstrated to enhance nuclear receptor activity in functional assays, suggesting that they may serve as nuclear receptor coregulators (reviewed in Ref. 1Glass C.K. Rosenfeld M.G. Genes Dev. 2000; 14: 121-141Crossref PubMed Google Scholar). Biochemical studies and protein-protein interaction screens suggest that many of these proteins function as components of large multiprotein complexes and that additional enzymatic activities may be important for their function. For example, the p160 protein GRIP1 can associate with arginine methyltransferase 1 (CARM1), which potentiates ligand-dependent transcription by several nuclear receptors (16Chen D. Ma H. Hong H. Koh S.S. Huang S.-M. Schurter B.T. Aswad D.W. Stallcup M.R. Science. 1999; 284: 2174-2176Crossref PubMed Scopus (1019) Google Scholar). PRMTI, a second arginine methyltransferase to also functions as a nuclear receptor coactivator S. Chen D. Lee Y. Stallcup M. J. Biol. Chem. 2001; 276: 1089-1098Abstract Full Text Full Text PDF PubMed Scopus (310) Google Scholar). The CBP/p300 coactivators can recruit additional factors with such as the complexes V.V. Schiltz R.L. Russanova V. Howard B.H. Nakatani Y. Cell. 1996; 87: 953-959Abstract Full Text Full Text PDF PubMed Scopus (2448) Google Scholar, R. Kalafus D. Ogliastro M.-H. Kioussi C. Xu L. Torchia J. Rosenfeld M.G. Glass C.K. Science. 1998; 279: 700-703Crossref PubMed Scopus (199) Google Scholar). The and of the recruited complexes may distinct acetyltransferases are required by transcription factors on specific gene targets E. Torchia J. Rose D.W. Xu L. Kurokawa R. E.M. Mullen T.M. Glass C.K. Rosenfeld M.G. Science. 1998; 279: PubMed Scopus Google Scholar). In to coactivator complexes that nucleosome remodeling or histone acetyltransferase other coactivator complexes have been identified. The characterized of these is the which the transcriptional activities of nuclear receptors and other transcription factors in J.D. M. S. Sci. S. A. 1999; PubMed Scopus Google Scholar, C. J. D. H. P. Genes Dev. 1998; 12: PubMed Scopus Google Scholar, P.A. S. S. W. R. Nature. 1999; PubMed Scopus Google Scholar). The complex is recruited to nuclear receptors in a ligand-dependent manner a referred to as which utilized LXXLL nuclear receptor interaction motifs J.W. F. Nature. PubMed Scopus Google Scholar, Y. C. S. J. Biol. Chem. 1997; 272: Full Text Full Text PDF PubMed Scopus Google Scholar). of the gene in the results in at and initial studies in enhancer factors have suggested a defect in ligand-dependent thyroid hormone and receptor function P.A. S. S. W. R. Nature. 1999; PubMed Scopus Google Scholar, J.W. F. Nature. PubMed Scopus Google Scholar). other classes of transcription factors to activate transcription in these The complex consists of more than a a of which appears to that are components of other including and and have enzymatic functions J.D. M. S. Sci. S. A. 1999; PubMed Scopus Google Scholar, P.A. S. S. W. R. Nature. 1999; PubMed Scopus Google Scholar, M. S. W. J.D. S. Zhang Qin J. Mol. Cell. 1999; Full Text Full Text PDF PubMed Scopus Google Scholar). These factors may function to recruit RNA polymerase II to nuclear receptors. The complex is not associated with RNA polymerase II but can be in the presence of vitamin D receptor C. V. M. A. H. P. L. Nature. 1999; PubMed Scopus Google Scholar), suggesting a conformational or recruitment of additional components that interactions with RNA polymerase II complexes. As more than additional coactivators have been including proteins with activity and an RNA that appears to function as a coactivator (reviewed in Ref. 15McKenna N.J. Lanz R.B. O'Malley B.W. Endocr. Rev. 1999; 20: 321-344Crossref PubMed Scopus (1669) Google Scholar), is that protein complexes can act either or in in of the of of interactions J. W. D. R. G. Science. 2000; PubMed Scopus Google Scholar, Y. J. M. Cell. 2000; Full Text Full Text PDF PubMed Scopus Google Scholar). potential for a of coactivators be for complexes to chromatin remodeling ligand-dependent recruitment of the so p160 factors, in with other factors such as p300, and p/CAF, required acetyltransferase recruitment of complexes such as the complex may function to enhance RNA polymerase II recruitment to the In addition, a number of factors have been that can act in a promoter-specific important enzymatic activities or protein-protein interactions and or with other complexes. For example, a coactivator both with nuclear receptors and CBP/p300 p160 factors or a a C-terminal domain and also contacts factors in the basal transcription complex S.L. J.E. L. J. D. B.H. Lee Lee J.W. J. Biol. Chem. 1999; Full Text Full Text PDF PubMed Scopus Google Scholar, F. P. M. E. J. Biol. Chem. 2000; Full Text Full Text PDF PubMed Scopus Google Scholar). has revealed promoter-specific in or on specific CBP and p300 are functionally M. D. R.T. E. D.M. R. Cell. 1998; Full Text Full Text PDF Scopus Google Scholar, Y. A. T. T. Y. M. H. T. K. K. Mol. 1999; PubMed Scopus Google Scholar), and studies in suggest in retinoic acid receptor the biochemical studies that of transcription requires of p300 and CBP Y. Xu L. T. Torchia J. Kurokawa R. Rose D.W. Glass C.K. Rosenfeld M.G. Cell. 1996; Full Text Full Text PDF PubMed Scopus Google Scholar). mice each of the p160 factors are are suggested in specific receptor functions J. Y. M.J. O'Malley B.W. Science. 1998; 279: PubMed Scopus Google Scholar, C. Y. J. N. V. S. T. Sci. S. A. 1999; PubMed Scopus Google Scholar, J. L. G. H. C. O'Malley B.W. Sci. S. A. 2000; PubMed Scopus Google Scholar, Rose D.W. F. T. W. D. A. Krones A. K. Rosenfeld R. Glass C.K. Rosenfeld M.G. Sci. S. A. 2000; PubMed Scopus Google for example, effects on cell events J. L. G. H. C. O'Malley B.W. Sci. S. A. 2000; PubMed Scopus Google Scholar, Rose D.W. F. T. W. D. A. Krones A. K. Rosenfeld R. Glass C.K. Rosenfeld M.G. Sci. S. A. 2000; PubMed Scopus Google Scholar). The for diverse coactivators in part, their and of coactivators, by the in CBP in specific cell H. 1999; PubMed Scopus Google Scholar). a is that the number of potential coregulators clearly exceeds the capacity for direct interaction by a single receptor. chromatin assays, complexes and complexes are found to be to estrogen receptor target genes in response to Y. J. M. Cell. 2000; Full Text Full Text PDF PubMed Scopus Google Scholar). these complexes each estrogen receptor be by this in of the of of receptors J. W. D. R. G. Science. 2000; PubMed Scopus Google Scholar). A of on the glucocorticoid response elements of induced was by the of glucocorticoid receptors in a cell containing a of units J. W. D. R. G. Science. 2000; PubMed Scopus Google Scholar). might that is a exchange of receptors associated with which mediate a of and required for transcriptional activation. A of a promoter-specific coactivator has been provided by identification of the coactivator P. R. M. Cell. 1998; Full Text Full Text PDF PubMed Scopus Google Scholar, P. Zhang C. G. V. A. S. Cell. 1999; 98: Full Text Full Text PDF PubMed Scopus Google Scholar). is induced in by and as a with CBP and p160 factors, for and transcriptional activation. These the of specific of coactivators are required for regulated by the nuclear receptor. Several members of the nuclear receptor family appear to critical roles by actively gene as a ligand-independent on target genes or a ligand-dependent on other transcription units (Fig. 1). A for interacting proteins mediating these effects led to the cloning of the nuclear receptor corepressors and A. A. T. Torchia J. Kurokawa R. Kamei Y. A. M. Glass C.K. PubMed Scopus Google Scholar, J.D. Nature. PubMed Scopus Google Scholar, S. Mol. 1996; PubMed Scopus Google Scholar). These factors domains that can interact with mammalian homologues of proteins that have been in yeast to mediate transcriptional including and histone T. Mullen T.-M. M. C.D. Torchia J. Yang G. E. Rose D.W. Glass C.K. Rosenfeld M.G. Nature. 1997; 387: PubMed Scopus Google Scholar, L. D. R.J. Hassig C.A. Schreiber S.L. Cell. 1997; 89: Full Text Full Text PDF PubMed Scopus Google Scholar). hormone can be with in the ligand binding domain of thyroid hormone receptor that enhance ligand-independent interactions with S.M. Mol. 1997; 11: PubMed Scopus Google Scholar). also repressive roles in the actions of other classes of transcription factors (reviewed in Ref. 1Glass C.K. Rosenfeld M.G. Genes Dev. 2000; 14: 121-141Crossref PubMed Google Scholar). has between and as deletion of the nuclear repression of specific genes K. T. A. V. R. Kurokawa R. V. F. E. S. G. Glass C.K. Rose D.W. Rosenfeld M.G. Cell. 2000; Full Text Full Text PDF PubMed Scopus Google Scholar). of transcription in mice and the at specific in and that is a required of short repression by nuclear receptors and other factors. In addition, also appears to be required for a of repression suggest that specific of corepressor and histone mediate the gene-specific actions of on the of multiple and appear to be components of several distinct corepressor complexes. both proteins suggested to interact with complexes containing and specific on T. Mullen T.-M. M. C.D. Torchia J. Yang G. E. Rose D.W. Glass C.K. Rosenfeld M.G. Nature. 1997; 387: PubMed Scopus Google Scholar, L. D. R.J. Hassig C.A. Schreiber S.L. Cell. 1997; 89: Full Text Full Text PDF PubMed Scopus Google Scholar), complexes biochemical not contain or of in of three distinct complexes P. L. N. P. Y. J. Biol. Chem. 2001; 276: Full Text Full Text PDF PubMed Scopus Google Scholar). complex and the second a histone and the complex activity. of complexes has also in the of at least three complexes C. M. S. Torchia J. J. Biol. Chem. 2000; Full Text Full Text PDF PubMed Scopus Google Scholar, J. Wang J. J. Qin J. J. J. 2000; 19: PubMed Scopus Google Scholar, M. W. W. E. M. Genes Dev. 2000; 14: PubMed Google Scholar, Y. V. L. Yang W. Glass C. Rosenfeld M. E. Sci. S. A. 2000; PubMed Scopus Google Scholar). complex and several other components found in the with the studies C. M. S. Torchia J. J. Biol. Chem. 2000; Full Text Full Text PDF PubMed Scopus Google Scholar). The second complex several additional components, including and a corepressor that has been to silencing T. Mullen T.-M. M. C.D. Torchia J. Yang G. E. Rose D.W. Glass C.K. Rosenfeld M.G. Nature. 1997; 387: PubMed Scopus Google Scholar). appears to be a of either or protein 1 a protein with and functional to the and corepressors M. W. W. E. M. Genes Dev. 2000; 14: PubMed Google Scholar). is also a of the complex M. W. W. E. M. Genes Dev. 2000; 14: PubMed Google Scholar, Y. V. L. Yang W. Glass C. Rosenfeld M. E. Sci. S. A. 2000; PubMed Scopus Google Scholar), as to the specific functions of in A specific conserved corepressor domain of and has also been to be capable of direct interaction with and Zhang J. M.G. Kouzarides T. Genes Dev. 2000; 14: Google Scholar, M. Nature. 1999; PubMed Scopus Google Scholar). In these suggest that with specific corepressor complexes are regulated and exhibit promoter and Two in the C-terminal regions of and appear to function to mediate interactions with thyroid hormone each containing a conserved consensus sequence that mediate interactions with thyroid and retinoic acid receptors M. Nature. 1999; PubMed Scopus Google Scholar, V. E.M. Kurokawa R. Krones A. Rose D.W. Lambert M.H. Milburn M.V. Glass C.K. Rosenfeld M.G. Genes Dev. 1999; PubMed Scopus Google Scholar, L. H. J. C. E. J. V. K. R. J. Genes Dev. 1999; PubMed Scopus Google Scholar). This motif is to form an α helical than the LXXLL motif in nuclear receptor Biochemical that the motif in and and the LXXLL motif in coactivators for with of the corepressor helix to in the a that a second of corepressor can be recruited to such as estrogen receptor in the presence of J.D. M.R. D. D.M. Science. 1999; Scopus Google Scholar), also appears to be a required K. T. A. V. R. Kurokawa R. V. F. E. S. G. Glass C.K. Rose D.W. Rosenfeld M.G. Cell. 2000; Full Text Full Text PDF PubMed Scopus Google Scholar, K. Torchia J. Mullen T.-M. R. M. S. J. C.K. Glass C.K. Rosenfeld M.G. Rose D.W. Sci. S. A. 1998; 95: PubMed Scopus Google Scholar). of the estrogen receptor to or of the AF-2 helix (e.g. Ref. 25Shiau A.K. Barstad D. Loria P.M. Cheng L. Kushner P.J. Agard D.A. Greene G.L. Cell. 1998; 95: 927-937Abstract Full Text Full Text PDF PubMed Scopus (2304) Google Scholar), corepressor that coactivators and corepressors are themselves targets of multiple pathways, of which are illustrated in Fig. Regulation of coactivator and corepressor function a for of to specific of sequence-specific transcription factors. For example, the histone acetyltransferase activity of CBP has been suggested to be regulated by which coactivator activities the cell S. S. F. L. P. M. D. A. Nature. 1998; PubMed Scopus Google Scholar). The ability of CBP to serve as a coactivator of is enhanced in response to signaling a mechanism S. H. Science. 1998; PubMed Scopus Google Scholar). The p160 nuclear receptors can be in response to signaling of the to the Rose D.W. F. T. W. D. A. Krones A. K. Rosenfeld R. Glass C.K. Rosenfeld M.G. Sci. S. A. 2000; PubMed Scopus Google Scholar). of lysine residues to LXXLL motifs may the receptors. corepressors are targets of pathways, with activation of with a of a nuclear to a or S. H. Science. 1998; PubMed Scopus Google C. R.J. W. D. Cell. 1999; 98: Full Text Full Text PDF PubMed Scopus Google Scholar). The N terminus of has been to interact with the mammalian homologue of Drosophila in Y. R. H. P. M. D. Mol. Cell. 1998; Full Text Full Text PDF PubMed Scopus Google Scholar), in of Based on cotransfection can mediate a decrease of protein by a The of with nuclear receptors is by cell signaling events that can the and activity of activation of signaling that the of with estrogen receptors in the presence of the on the of the N terminus K. Torchia J. Mullen T.-M. R. M. S. J. C.K. Glass C.K. Rosenfeld M.G. Rose D.W. Sci. S. A. 1998; 95: PubMed Scopus Google Scholar). In addition, with or in of and of with 1 directly interactions between and nuclear receptors or S. M. Mol. Cell. Biol. 2000; 20: PubMed Scopus Google Scholar). Nuclear receptors can serve as or dependent the regulated exchange of binding of factors and characterized by distinct enzymatic and platform In to a ligand-dependent can interactions of specific coregulators with nuclear receptors or mediate their activity or between nuclear or The potential for exchange of nuclear receptors and has for the functional of multiple receptors of coregulatory complexes.

SummaryResistance to thyroid hormone (RTH) is a clinical disorder without specific and effective therapeutic strategy, partly due to the lack of structural mechanisms for the defective ligand binding by mutated thyroid hormone receptors (THRs). We herein uncovered the prescription drug roxadustat as a novel THRβ-selective ligand with therapeutic potentials in treating RTH, thereby providing a small molecule tool enabling the first probe into the structural mechanisms of RTH. Despite a wide distribution of the receptor mutation sites, different THRβ mutants induce allosteric conformational modulation on the same His435 residue, which disrupts a critical hydrogen bond required for the binding of thyroid hormones. Interestingly, roxadustat retains hydrophobic interactions with THRβ via its unique phenyl extension, enabling the rescue of the activity of the THRβ mutants. Our study thus reveals a critical receptor allosterism mechanism for RTH by mutant THRβ, providing a new and viable therapeutic strategy for the treatment of RTH.

Chapter 47 - Modulating vitamin D receptor–coregulator binding with small molecules